08.10.2007 13:00:00

Safeguard Scientifics Hosts 'Analyst Day 2007'

Safeguard Scientifics, Inc. (NYSE: SFE), a holding company which builds value in growth-stage technology and life sciences companies, will be hosting ‘Analyst Day 2007’ in New York, NY tomorrow, Tuesday, October 9. Analyst Day will offer the institutional investor community an opportunity to hear from key members of Safeguard’s leadership team as well as CEOs from select Safeguard partner companies. Safeguard executives include: Peter J. Boni, President and CEO; Raymond J. Land, Senior Vice President and CFO; James A. Datin, Executive Vice President and Managing Director, Life Sciences; John A. Loftus, Executive Vice President and Managing Director, Technology; Kevin L. Kemmerer, Senior Vice President, Technology. Life Sciences Partner Company CEOs include: Ron A. Andrews, President and CEO, Clarient, Inc. (Nasdaq: CLRT); Daniel M. Skovronsky, MD, PhD, Founder and CEO, Avid Radiopharmaceuticals, Inc.; Robert J. Broeze, PhD, President and CEO, Laureate Pharma, Inc.; Kevin Rakin, CEO, Advanced BioHealing, Inc. Technology Partner Company CEOs include: Anthony A. Ibargüen, President and CEO, Alliance Consulting Group Associates, Inc.; Richard P. Milgram, Founder and CEO, Beyond.com, Inc.; Vinny Olmstead, President and CEO, Broadband National, Inc.; John C. Sharp, CEO, Authentium, Inc. WEBCAST / PRESENTATION INFORMATION Date: Tuesday, October 9, 2007 Start Time: 8:00am ET Location: St. Regis Hotel, New York, NY Webcast: www.safeguard.com/AnalystDay2007 Speakers: Peter J. Boni, President and CEO; Raymond J. Land, CFO; Key Members of Safeguard's leadership team; CEOs of select Safeguard partner companies. About Safeguard Safeguard Scientifics, Inc. (NYSE:SFE), a holding company, builds value in growth-stage technology and life sciences businesses. Safeguard provides growth capital as well as a range of strategic, operational and management resources to our partner companies. Safeguard participates in growth buyout financings, including corporate spin-outs and management buyouts, expansion financings, industry consolidations and early-stage financings. www.safeguard.com

Nachrichten zu Safeguard Scientifics Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Safeguard Scientifics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!